Skip to main content
. 2022 Jun 24;22:695. doi: 10.1186/s12885-022-09778-9

Table 1.

Characteristics of colorectal cancer patients by C-reactive protein (CRP) quintiles

Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
N 248 245 249 247 246
CRP Quintile ranges, mg/L 0.20–0.73 0.74–1.81 1.82–3.31 3.32–5.57 ≥ 5.58
CRP, mg/L, median (Q25, Q75) 0.34 (0.20, 0.47) 1.19 (0.95, 1.45) 2.53 (2.16, 2.87) 4.21 (3.65, 4.87) 8.86 ( 6.82–13.02)
Female sex, n (%) 131 (52.8) 111 (45.3) 113 (45.4) 133 (53.8) 138 (56.1)
Age at diagnosis, years, mean (SD) 61.0 (7.4) 62.3 (7.4) 62.4 (7.1) 63.3 (7.0) 63.1 (7.3)
Current smoking, n (%) 74 (29.8) 52 (21.2) 61 (24.5) 67 (27.1) 58 (23.6)
Physical activity (MET-hours/week), mean (SD) 83.6 (52.7) 85.7 (55.5) 81.7 (50.1) 85.2 (51.7) 86.5 (54.9)
Body mass index, kg/m2, mean (SD) 24.5 (3.4) 26.0 (3.6) 26.7 (3.8) 27.4 (4.1) 28.9 (5.3)
Waist circumference, cm, mean (SD) 84.1 (11.9) 88.9 (12.6) 90.8 (11.9) 92.3 (12.5) 95.9 (13.8)
Diabetes, n (%) 12 ( 5.0) 14 ( 5.9) 17 ( 6.9) 36 (14.7) 44 (18.6)
Family history of CRC, n (%) 6 ( 9.7) 4 ( 6.7) 4 ( 7.1) 6 ( 8.8) 7 (10.3)
Location of primary tumor, n (%)
  Colon 152 (61.3) 139 (56.7) 148 (59.4) 160 (64.8) 181 (73.6)
  Rectum 96 (38.7) 106 (43.3) 101 (40.6) 87 (35.2) 65 (26.4)
Grade of differentiation, n (%)
  Well differentiated 16 (6.5) 11 (4.5) 15 (6.0) 15 (6.1) 14 (5.7)
  Moderately differentiated 66 (26.6) 65 (26.5) 73 (29.3) 81 (32.8) 74 (30.1)
  Poorly differentiated 14 (5.6) 21 (8.6) 17 (6.8) 9 (3.6) 20 (8.1)
  Unknown 152 (61.3) 148 (60.4) 144 (57.8) 142 (57.5) 138 (56.1)
Stage, n (%)
  I 73 (29.4) 66 (26.9) 64 (25.7) 46 (18.6) 58 (23.6)
  II 58 (23.4) 41 (16.7) 51 (20.5) 54 (21.9) 53 (21.5)
  III 56 (22.6) 79 (32.2) 69 (27.7) 85 (34.4) 81 (32.9)
  IV 25 (10.1) 20 (8.2) 34 (13.7) 34 (13.8) 32 (13.0)
  Unknown 36 (14.5) 39 (15.9) 31 (12.4) 28 (11.3) 22 (8.9)